Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.
J Clin Endocrinol Metab. 2022 Aug 18;107(9):2598-2605. doi: 10.1210/clinem/dgac363.
Minipuberty, a period of a transient activation of the hypothalamic-pituitary-gonadal (HPG) axis in both sexes, enables evaluation of gonadal function in infants suspected of hypogonadism. However, female minipuberty remains poorly elucidated.
We aimed to establish continuous reference ranges for the most commonly used reproductive hormones and to evaluate the dynamics of the HPG axis in females aged 0 to 1 year.
The COPENHAGEN Minipuberty Study (ClinicalTrials.gov ID: NCT02784184), a longitudinal, prospective cohort study.
Healthy infants from Copenhagen.
A total of 98 healthy, term female infants followed with 6 examinations including venipuncture during the first year of life.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Serum concentrations of LH, FSH, inhibin B, anti-Müllerian hormone (AMH), estrone (E1), estradiol (E2), and SHBG were quantified using highly sensitive methods in 266 serum samples.
Reference ranges were established for LH, FSH, inhibin B, AMH, E1, E2, and SHBG. Two peaks were observed in normalized mean curves for all hormones. The first peaks were timed around postnatal days 15 to 27 followed by a general nadir for all hormones around days 58 to 92. The second peaks occurred around days 107 to 125 for inhibin B, AMH, E1, E2, and SHBG and days 164 to 165 for LH and FSH.
We present age-related, continuous reference ranges of the most commonly used reproductive hormones and present novel data revealing a biphasic and prolonged female minipuberty.
CLINICALTRIALS.GOV ID: NCT02784184.
两性的下丘脑-垂体-性腺(HPG)轴短暂激活的时期即迷你青春期,使怀疑患有性腺功能减退症的婴儿的性腺功能能够得到评估。然而,女性迷你青春期仍未得到充分阐述。
我们旨在建立最常用生殖激素的连续参考范围,并评估 0 至 1 岁女性 HPG 轴的动态。
哥本哈根迷你青春期研究(ClinicalTrials.gov 标识符:NCT02784184),一项纵向、前瞻性队列研究。
哥本哈根的健康婴儿。
98 名健康的足月女婴,在生命的第一年进行了 6 次检查,包括静脉采血。
无。
使用高度敏感的方法在 266 份血清样本中定量测定 LH、FSH、抑制素 B、抗苗勒管激素(AMH)、雌酮(E1)、雌二醇(E2)和 SHBG 的血清浓度。
建立了 LH、FSH、抑制素 B、AMH、E1、E2 和 SHBG 的参考范围。所有激素的归一化平均曲线均观察到两个峰值。第一个峰值出现在出生后 15 至 27 天左右,随后所有激素的总体低谷出现在 58 至 92 天左右。第二个峰值出现在抑制素 B、AMH、E1、E2 和 SHBG 的第 107 至 125 天左右,LH 和 FSH 的第 164 至 165 天左右。
我们提出了与年龄相关的最常用生殖激素的连续参考范围,并提供了揭示两性迷你青春期呈双峰和延长的新数据。
临床试验.gov 标识符:NCT02784184。